Within the TME, the BTLA-HVEM axis delivers inhibitory signals that suppress effector T cell activity, promote exhaustion, and reduce cytokine production, particularly in CD8+ tumor-infiltrating lymphocytes [236]. This evidence concerns the gene CD8A and neoplasm.